<DOC>
	<DOCNO>NCT00807911</DOCNO>
	<brief_summary>The purpose study evaluate disease-free survival patient locally advanced rectal cancer treat preoperative chemoradiotherapy fluoropyrimidines surgery follow adjuvant combination chemotherapy oxaliplatin/5-FU/Leucovorin vs 5-FU/Leucovorin .</brief_summary>
	<brief_title>Adjuvant Chemotherapy After Preoperative Chemoradiotherapy Treat Rectal Cancer</brief_title>
	<detailed_description>Preoperative chemoradiotherapy fluoropyrimidines follow surgery one standard treatments patient locally advanced rectal cancer ; however , role adjuvant chemotherapy still controversial . The aim study investigate efficacy adjuvant FOLFOX rectal cancer underwent fluoropyrimidine base chemoradiotherapy complete total mesorectal excision .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1 . Histologically confirm adenocarcinoma rectum 2 . Patients treat preoperative chemoradiation fluoropyrimidines follow curative surgery without microscopic residual tumor . 3 . AJCC/UICC pathologic stage ypT34 ypN+ 4 . Curative surgery le 3 8 week prior randomization 5 . No prior chemotherapy , radiotherapy immunotherapy except preoperative chemoradiation rectal cancer 6 . ECOG PS 01 7 . Adequate organ function 8 . Informed Consent 1 . Macroscopic microscopic evidence remain tumor 2 . Any histologic feature adenocarcinoma arise chronic inflammatory bowel disease 3 . More 8 week curative surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>adjuvant chemotherapy</keyword>
	<keyword>FOLFOX</keyword>
</DOC>